174 related articles for article (PubMed ID: 24846287)
1. Raised soluble P-selectin moderately accelerates atherosclerotic plaque progression.
Woollard KJ; Lumsden NG; Andrews KL; Aprico A; Harris E; Irvine JC; Jefferis AM; Fang L; Kanellakis P; Bobik A; Chin-Dusting JP
PLoS One; 2014; 9(5):e97422. PubMed ID: 24846287
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
[TBL] [Abstract][Full Text] [Related]
3. Shear stress-induced atherosclerotic plaque composition in ApoE(-/-) mice is modulated by connexin37.
Pfenniger A; Meens MJ; Pedrigi RM; Foglia B; Sutter E; Pelli G; Rochemont V; Petrova TV; Krams R; Kwak BR
Atherosclerosis; 2015 Nov; 243(1):1-10. PubMed ID: 26342936
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo.
Heim C; Gebhardt J; Ramsperger-Gleixner M; Jacobi J; Weyand M; Ensminger SM
Heart Vessels; 2016 May; 31(5):783-94. PubMed ID: 26062773
[TBL] [Abstract][Full Text] [Related]
5. P-Selectin Expressed by a Human SELP Transgene Is Atherogenic in Apolipoprotein E-Deficient Mice.
Zhang N; Liu Z; Yao L; Mehta-D'souza P; McEver RP
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1114-21. PubMed ID: 27102967
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
7. Hexim1 heterozygosity stabilizes atherosclerotic plaque and decreased steatosis in ApoE null mice fed atherogenic diet.
Dhar-Mascareno M; Rozenberg I; Iqbal J; Hussain MM; Beckles D; Mascareno E
Int J Biochem Cell Biol; 2017 Feb; 83():56-64. PubMed ID: 28013147
[TBL] [Abstract][Full Text] [Related]
8. Absence of the Vitamin D Receptor Inhibits Atherosclerotic Plaque Calcification in Female Hypercholesterolemic Mice.
Shamsuzzaman S; Onal M; St John HC; Jeffery JJ; Pike JW
J Cell Biochem; 2017 May; 118(5):1050-1064. PubMed ID: 27567005
[TBL] [Abstract][Full Text] [Related]
9. AnxA5 reduces plaque inflammation of advanced atherosclerotic lesions in apoE(-/-) mice.
Burgmaier M; Schutters K; Willems B; van der Vorst EP; Kusters D; Chatrou M; Norling L; Biessen EA; Cleutjens J; Perretti M; Schurgers LJ; Reutelingsperger CP
J Cell Mol Med; 2014 Oct; 18(10):2117-24. PubMed ID: 25214012
[TBL] [Abstract][Full Text] [Related]
10. Local gene silencing of monocyte chemoattractant protein-1 prevents vulnerable plaque disruption in apolipoprotein E-knockout mice.
Liu XL; Zhang PF; Ding SF; Wang Y; Zhang M; Zhao YX; Ni M; Zhang Y
PLoS One; 2012; 7(3):e33497. PubMed ID: 22428064
[TBL] [Abstract][Full Text] [Related]
11. Dietary cholesterol oxidation products accelerate plaque destabilization and rupture associated with monocyte infiltration/activation via the MCP-1-CCR2 pathway in mouse brachiocephalic arteries: therapeutic effects of ezetimibe.
Sato K; Nakano K; Katsuki S; Matoba T; Osada K; Sawamura T; Sunagawa K; Egashira K
J Atheroscler Thromb; 2012; 19(11):986-98. PubMed ID: 22785139
[TBL] [Abstract][Full Text] [Related]
12. ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice.
Gandhi C; Khan MM; Lentz SR; Chauhan AK
Blood; 2012 Mar; 119(10):2385-91. PubMed ID: 22123843
[TBL] [Abstract][Full Text] [Related]
13. Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice.
Sastre C; Fernández-Laso V; Madrigal-Matute J; Muñoz-García B; Moreno JA; Pastor-Vargas C; Llamas-Granda P; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
J Cell Mol Med; 2014 Apr; 18(4):721-34. PubMed ID: 24479820
[TBL] [Abstract][Full Text] [Related]
14. Genetic deletion of LXRα prevents arsenic-enhanced atherosclerosis, but not arsenic-altered plaque composition.
Lemaire M; Lemarié CA; Flores Molina M; Guilbert C; Lehoux S; Mann KK
Toxicol Sci; 2014 Dec; 142(2):477-88. PubMed ID: 25273567
[TBL] [Abstract][Full Text] [Related]
15. Acid fibroblast growth factor facilitates the progression of atherosclerotic plaques regardless of alterations in serum lipid expression levels in HFD‑fed ApoE‑/‑ mice.
Han J; Du Y; Wang L; Chen X; Jiang L; Xu J
Mol Med Rep; 2018 Jul; 18(1):1025-1030. PubMed ID: 29845277
[TBL] [Abstract][Full Text] [Related]
16. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
[TBL] [Abstract][Full Text] [Related]
17. Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules.
Tikellis C; Jandeleit-Dahm KA; Sheehy K; Murphy A; Chin-Dusting J; Kling D; Sebokova E; Cooper ME; Mizrahi J; Woollard KJ
Atherosclerosis; 2008 Jul; 199(1):55-64. PubMed ID: 18093596
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages.
Nazari-Jahantigh M; Wei Y; Noels H; Akhtar S; Zhou Z; Koenen RR; Heyll K; Gremse F; Kiessling F; Grommes J; Weber C; Schober A
J Clin Invest; 2012 Nov; 122(11):4190-202. PubMed ID: 23041630
[TBL] [Abstract][Full Text] [Related]
19. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
[TBL] [Abstract][Full Text] [Related]
20. CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice.
Gutiérrez-Muñoz C; Méndez-Barbero N; Svendsen P; Sastre C; Fernández-Laso V; Quesada P; Egido J; Escolá-Gil JC; Martín-Ventura JL; Moestrup SK; Blanco-Colio LM
FASEB J; 2020 Nov; 34(11):14960-14976. PubMed ID: 32924185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
